198 related articles for article (PubMed ID: 27267703)
1. Does a methionine-to-norleucine substitution in PGLa influence peptide-membrane interactions?
Radchenko DS; Kattge S; Kara S; Ulrich AS; Afonin S
Biochim Biophys Acta; 2016 Sep; 1858(9):2019-2027. PubMed ID: 27267703
[TBL] [Abstract][Full Text] [Related]
2. Solid-state NMR analysis comparing the designer-made antibiotic MSI-103 with its parent peptide PGLa in lipid bilayers.
Strandberg E; Kanithasen N; Tiltak D; Bürck J; Wadhwani P; Zwernemann O; Ulrich AS
Biochemistry; 2008 Feb; 47(8):2601-16. PubMed ID: 18220419
[TBL] [Abstract][Full Text] [Related]
3. Control and role of pH in peptide-lipid interactions in oriented membrane samples.
Misiewicz J; Afonin S; Ulrich AS
Biochim Biophys Acta; 2015 Mar; 1848(3):833-41. PubMed ID: 25511586
[TBL] [Abstract][Full Text] [Related]
4. Orientation of the antimicrobial peptide PGLa in lipid membranes determined from 19F-NMR dipolar couplings of 4-CF3-phenylglycine labels.
Glaser RW; Sachse C; Dürr UH; Wadhwani P; Ulrich AS
J Magn Reson; 2004 May; 168(1):153-63. PubMed ID: 15082261
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the amino acid CF3-bicyclopentylglycine as a new label for solid-state 19 F-NMR structure analysis of membrane-bound peptides.
Afonin S; Mikhailiuk PK; Komarov IV; Ulrich AS
J Pept Sci; 2007 Sep; 13(9):614-23. PubMed ID: 17694569
[TBL] [Abstract][Full Text] [Related]
6. High-resolution structural profile of hylaseptin-4: Aggregation, membrane topology and pH dependence of overall membrane binding process.
Nunes LO; Munhoz VHO; Sousa AA; de Souza KR; Santos TL; Bemquerer MP; Ferreira DEC; de Magalhães MTQ; Resende JM; Alcântara AFC; Aisenbrey C; Veloso DP; Bechinger B; Verly RM
Biochim Biophys Acta Biomembr; 2021 May; 1863(5):183581. PubMed ID: 33556358
[TBL] [Abstract][Full Text] [Related]
7. (19)F NMR screening of unrelated antimicrobial peptides shows that membrane interactions are largely governed by lipids.
Afonin S; Glaser RW; Sachse C; Salgado J; Wadhwani P; Ulrich AS
Biochim Biophys Acta; 2014 Sep; 1838(9):2260-8. PubMed ID: 24699372
[TBL] [Abstract][Full Text] [Related]
8. Homo- and heteromeric interaction strengths of the synergistic antimicrobial peptides PGLa and magainin 2 in membranes.
Zerweck J; Strandberg E; Bürck J; Reichert J; Wadhwani P; Kukharenko O; Ulrich AS
Eur Biophys J; 2016 Sep; 45(6):535-47. PubMed ID: 27052218
[TBL] [Abstract][Full Text] [Related]
9. Deletion of all cysteines in tachyplesin I abolishes hemolytic activity and retains antimicrobial activity and lipopolysaccharide selective binding.
Ramamoorthy A; Thennarasu S; Tan A; Gottipati K; Sreekumar S; Heyl DL; An FY; Shelburne CE
Biochemistry; 2006 May; 45(20):6529-40. PubMed ID: 16700563
[TBL] [Abstract][Full Text] [Related]
10. Concentration-dependent realignment of the antimicrobial peptide PGLa in lipid membranes observed by solid-state 19F-NMR.
Glaser RW; Sachse C; Dürr UH; Wadhwani P; Afonin S; Strandberg E; Ulrich AS
Biophys J; 2005 May; 88(5):3392-7. PubMed ID: 15695635
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanism of synergy between the antimicrobial peptides PGLa and magainin 2.
Zerweck J; Strandberg E; Kukharenko O; Reichert J; Bürck J; Wadhwani P; Ulrich AS
Sci Rep; 2017 Oct; 7(1):13153. PubMed ID: 29030606
[TBL] [Abstract][Full Text] [Related]
12. Structure analysis of the membrane-bound dermcidin-derived peptide SSL-25 from human sweat.
Mühlhäuser P; Wadhwani P; Strandberg E; Bürck J; Ulrich AS
Biochim Biophys Acta Biomembr; 2017 Dec; 1859(12):2308-2318. PubMed ID: 28888369
[TBL] [Abstract][Full Text] [Related]
13. Diphytanoyl lipids as model systems for studying membrane-active peptides.
Kara S; Afonin S; Babii O; Tkachenko AN; Komarov IV; Ulrich AS
Biochim Biophys Acta Biomembr; 2017 Oct; 1859(10):1828-1837. PubMed ID: 28587828
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of antibacterial action of dermaseptin B2: interplay between helix-hinge-helix structure and membrane curvature strain.
Galanth C; Abbassi F; Lequin O; Ayala-Sanmartin J; Ladram A; Nicolas P; Amiche M
Biochemistry; 2009 Jan; 48(2):313-27. PubMed ID: 19113844
[TBL] [Abstract][Full Text] [Related]
15. Biological activity and structural aspects of PGLa interaction with membrane mimetic systems.
Lohner K; Prossnigg F
Biochim Biophys Acta; 2009 Aug; 1788(8):1656-66. PubMed ID: 19481533
[TBL] [Abstract][Full Text] [Related]
16. Synergistic transmembrane alignment of the antimicrobial heterodimer PGLa/magainin.
Tremouilhac P; Strandberg E; Wadhwani P; Ulrich AS
J Biol Chem; 2006 Oct; 281(43):32089-94. PubMed ID: 16877761
[TBL] [Abstract][Full Text] [Related]
17. 4-fluorophenylglycine as a label for 19F NMR structure analysis of membrane-associated peptides.
Afonin S; Glaser RW; Berditchevskaia M; Wadhwani P; Gührs KH; Möllmann U; Perner A; Ulrich AS
Chembiochem; 2003 Nov; 4(11):1151-63. PubMed ID: 14613106
[TBL] [Abstract][Full Text] [Related]
18. Structure and dynamics of the antibiotic peptide PGLa in membranes by solution and solid-state nuclear magnetic resonance spectroscopy.
Bechinger B; Zasloff M; Opella SJ
Biophys J; 1998 Feb; 74(2 Pt 1):981-7. PubMed ID: 9533709
[TBL] [Abstract][Full Text] [Related]
19. Substitution of the methionine residues of calmodulin with the unnatural amino acid analogs ethionine and norleucine: biochemical and spectroscopic studies.
Yuan T; Vogel HJ
Protein Sci; 1999 Jan; 8(1):113-21. PubMed ID: 10210190
[TBL] [Abstract][Full Text] [Related]
20. Dermaseptin S9, an alpha-helical antimicrobial peptide with a hydrophobic core and cationic termini.
Lequin O; Ladram A; Chabbert L; Bruston F; Convert O; Vanhoye D; Chassaing G; Nicolas P; Amiche M
Biochemistry; 2006 Jan; 45(2):468-80. PubMed ID: 16401077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
